Actinolysate® (Aktinolysat®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspsolution for intramuscular injection
Composition:

For 1 ml of the preparation: lysate actinomycetes genera: Actinomyces - 0.5 ml, Micromonospora - 0.5 ml.

Description:Transparent solution from yellowish brown to brown.
Pharmacotherapeutic group:MIBP
ATX: & nbsp
  • Other immunostimulants
    • Pharmacodynamics:

    Actinolysate stimulates the phagocytic process in the body, has a powerful, immunomodulating effect, stimulates the production of antibodies to various infectants and increases the resistance of the organism.

    Actinolysate reduces the intensity of the inflammatory process due to inhibition of hyperproduction of cytokines and blockade of the action of inflammatory mediators.

    Indications:

    Actinomycosis of various localizations, bacterial purulent and inflammatory diseases of the skin, mucous membranes, subcutaneous tissue, bones, trophic ulcers, acne, furunculosis, long-term non-healing wounds, diabetic foot syndrome, odontogenic inflammatory process, mastitis, sinusitis, tonsillitis, otitis media, bronchitis, pneumonia, lung abscess, esophagitis, gastritis, hepatitis, enterocolitis, pyelonephritis, prostatitis, urethritis, vulvovaginitis, cystitis, paraproctitis and other inflammatory diseases.

    Contraindications:

    Malignant neoplasms, acute infectious diseases (influenza, acute respiratory viral infections, intestinal infections), individual intolerance.

    Pregnancy and lactation:

    When pregnancy apply in the event that the intended benefit to the mother exceeds the potential risk to the fetus. The study of reproduction on animals did not reveal the risk of adverse effects on the fetus, and adequate and strictly controlled studies in pregnant women were not conducted.

    Application in the period of breastfeeding is not recommended (there are no data on the penetration of the drug into breast milk).

    Dosing and Administration:

    Intramuscular, 2 times a week.

    Children under 3 years of age - 0.1 ml per 1 kg of body weight, from 3 to 14 years - 2 ml, over 14 years and adults - 3 ml.

    The course of treatment consists of 5-25 injections:

    with skin diseases - 5-15 injections;

    with internal diseases - 10-15 injections;

    with actinomycosis - 20-25 injections.

    Interval between courses - 1 month, the number of treatment courses (from 2 to 4 or more) depends on the form and severity of the disease.

    1 month after the clinical recovery in order to avoid relapse, a preventive course of 5-15 injections is carried out.

    Side effects:A natural light increase in inflammation in the pathological focus after the first injections (withdrawal of the drug is not required); allergic reactions: a rash on the skin, hyperemia at the injection site,short-term subfebrile condition, which quickly stop after taking antihistamines; In the absence of a positive effect, the drug should be discarded.
    Overdose:

    Cases of an overdose have not been revealed.

    Interaction:

    Actinolysate® enhances the effect of antibacterial drugs.

    Effect on the ability to drive transp. cf. and fur:

    Not was studied.

    Form release / dosage:Solution for intramuscular injection.
    Packaging:

    In ampoules of 2 or 3 ml; 5 ampoules together with instructions for use and an ampoule knife in a contour acheive box or cardboard box.

    Storage conditions:Keep in accordance with the requirements of SP 3.3.2.1248-03 at a temperature of 4 to 8 ° C, in a dark place out of the reach of children.
    To transport at a temperature of 4 to 25 ° C during the day.
    Shelf life:

    2 years.

    The drug with expired shelf life is not subject to application.

    Terms of leave from pharmacies:On prescription
    Registration number:LS-001204
    Date of registration:11.09.2012
    Expiration Date:Unlimited
    The owner of the registration certificate:ACTINYA, LLC ACTINYA, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp01.07.2017
    Illustrated instructions
      Instructions
      Up